Irwin A. Heyman

cis-Dichlorodiammineplatinum(II) (NSC-119 875): Preclinical toxicologic evaluation of intravenous injection in dogs, monkeys and mice

U. Schaeppi, Irwin A. Heyman, Robert W. Fleischman et al. · Toxicology and Applied Pharmacology · 1973 · 132 citations

Medicine, Pharmacology, Toxicology +13

Inhalation, parenteral and oral LD50 values of Δ9-tetrahydrocannabinol in Fischer rats

Harris Rosenkrantz, Irwin A. Heyman, Monique C. Braude · Toxicology and Applied Pharmacology · 1974 · 46 citations

Pharmacy, Pharmacology, Toxicology +9

Early rapid identification of in vivo rat metabolites of AN6414, a novel boron-containing PDE4 inhibitor by QTRAP LC/MS/MS to support drug discovery

Wei Bu, Tsutomu Akama, Sanjay Chanda et al. · Journal of Pharmaceutical and Biomedical Analysis · 2012 · 27 citations

Pharmacy, Medicinal Chemistry, Pharmacology +7

Differential neurochemistry and temporal pattern in rats treated orally with Δ9-tetrahydrocannabinol for periods up to six months

Yugal K. Luthra, Harris Rosenkrantz, Irwin A. Heyman et al. · Toxicology and Applied Pharmacology · 1975 · 26 citations

Life Sciences, Neuroscience, Pharmacology +11

A direct LC/MS/MS method for the determination of ciclopirox penetration across human nail plate in in vitro penetration studies

Wei Bu, Xiaoqing Fan, Holly Sexton et al. · Journal of Pharmaceutical and Biomedical Analysis · 2009 · 20 citations

Pharmacy, Pharmaceutics, Bioavailability +7